Will a warning label regarding potential suicide risks be added to Ozempic's labeling by June 30, 2024?
Basic
11
Ṁ1131resolved Jul 2
Resolved
NO1D
1W
1M
ALL
This market resolves to 'yes' if Ozempic's manufacturer or the FDA announces the inclusion of a warning label regarding potential suicide risks before or on June 30, 2024. Such an announcement must appear on official communication channels or major news publications. The market end date is June 30, 2024.
Get
1,000and
1.00
1,0001.00Related questions
Related questions
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
48% chance
Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
62% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
64% chance
Will there be a recall of Wegovy/Ozempic before 2035?
62% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
43% chance
The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
23% chance
Will AOH1996 be FDA approved before 2040?
44% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
33% chance
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
11% chance
Will Ozempic be ranked within the top three prescribed drugs for diabetes by June 30, 2024?
2% chance